Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VuCOMP develops advanced computer-aided detection (CAD) systems for automated analysis of mammographic images to assist radiologists in early breast cancer detection. Its flagship product, M-Vu CAD, uses sophisticated computer vision algorithms to automatically identify suspicious areas on mammograms, aiming to improve detection rates and support earlier intervention. The company has received multiple FDA approvals for its systems and has demonstrated improvements in mass detection sensitivity through continuous algorithm updates. VuCOMP's products are used in clinical settings worldwide, supporting radiologists with advanced diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VuCOMP.